Press Releases

We are proud to introduce our latest innovation — recombinant Influenza A virus subtype H5N1 Controls, developed to provide high-quality, reliable tools for both research and diagnostic applications. Product Highlights: These controls are designed to support influenza virus monitoring, antiviral resistance research, and diagnostic assay development, ensuring accuracy, reproducibility, and...

We are excited to announce the launch of our POLE-POLD1 Mutation Controls, designed to support researchers and clinicians in advancing cancer diagnostics and immunotherapy research. About POLE-POLD1 mutations:POLE-POLD1 mutations affect DNA replication and proofreading functions, leading to increased mutational burden and conditions such as Polymerase Proofreading-Associated Polyposis (PPAP) syndrome. While...

We’re excited to announce the launch of our BCR-ABL1 Control Panels, designed to support laboratories and researchers in monitoring the performance of quantitative detection of BCR-ABL1 translocation mRNA transcripts. These panels provide high-quality reference material for e14a2 (p210), e13a2 (p210), e1a2 (p190) transcripts, and the ABL1 endogenous control mRNA transcript,...